SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Y-mAbs Therapeutics, Inc. – ‘10-Q’ for 6/30/21 – ‘XML’

On:  Monday, 8/9/21, at 4:03pm ET   ·   For:  6/30/21   ·   Accession #:  1558370-21-10959   ·   File #:  1-38650

Previous ‘10-Q’:  ‘10-Q’ on 5/6/21 for 3/31/21   ·   Next:  ‘10-Q’ on 11/4/21 for 9/30/21   ·   Latest:  ‘10-Q’ on 11/13/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/21  Y-mAbs Therapeutics, Inc.         10-Q        6/30/21   76:7.2M                                   Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.24M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document and Entity Information                     HTML     75K 
13: R2          Consolidated Balance Sheets                         HTML     98K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     34K 
15: R4          Consolidated Statements of Net Income/(Loss) and    HTML     87K 
                Comprehensive Income/(Loss)                                      
16: R5          Consolidated Statements of Changes in               HTML     82K 
                Stockholders' Equity                                             
17: R6          Consolidated Statements of Cash Flows               HTML     87K 
18: R7          Organization and Description of Business            HTML     24K 
19: R8          Basis of Presentation                               HTML     29K 
20: R9          Summary of Significant Accounting Policies          HTML     78K 
21: R10         Product Revenue                                     HTML     54K 
22: R11         Net Loss Per Share                                  HTML     54K 
23: R12         Inventory                                           HTML     38K 
24: R13         Accrued Liabilities                                 HTML     42K 
25: R14         License Agreements and Commitments                  HTML    135K 
26: R15         Stockholders' Equity                                HTML     30K 
27: R16         Share-Based Compensation                            HTML     92K 
28: R17         Related Party Transactions                          HTML     25K 
29: R18         Income Taxes                                        HTML     27K 
30: R19         Other Benefits                                      HTML     24K 
31: R20         Gain From Sale of Priority Review Voucher           HTML     25K 
32: R21         Summary of Significant Accounting Policies          HTML    105K 
                (Policies)                                                       
33: R22         Summary of Significant Accounting Policies          HTML     59K 
                (Tables)                                                         
34: R23         Product Revenue (Tables)                            HTML     49K 
35: R24         Net Loss Per Share (Tables)                         HTML     52K 
36: R25         Inventory (Tables)                                  HTML     39K 
37: R26         Accrued Liabilities (Tables)                        HTML     41K 
38: R27         License Agreements and Commitments (Tables)         HTML    129K 
39: R28         Share-Based Compensation (Tables)                   HTML     84K 
40: R29         BASIS OF PRESENTATION - Accumulated deficit         HTML     24K 
                (Details)                                                        
41: R30         BASIS OF PRESENTATION - Secondary public offering   HTML     34K 
                (Details)                                                        
42: R31         BASIS OF PRESENTATION - Cash and cash equivalents   HTML     24K 
                (Details)                                                        
43: R32         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     29K 
                Concentration of Credit Risk (Details)                           
44: R33         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair   HTML     40K 
                Value Measurement (Details)                                      
45: R34         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     44K 
                Revenue Recognition - License Revenue (Details)                  
46: R35         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     23K 
                Segment (Details)                                                
47: R36         PRODUCT REVENUE - Discounts and Allowances          HTML     58K 
                (Details)                                                        
48: R37         PRODUCT REVENUE - Concentrations (Details)          HTML     33K 
49: R38         NET LOSS PER SHARE - Basic and diluted (Details)    HTML     47K 
50: R39         NET LOSS PER SHARE - Anti-dilutive securities       HTML     23K 
                (Details)                                                        
51: R40         Inventory (Details)                                 HTML     28K 
52: R41         Accrued Liabilities (Details)                       HTML     36K 
53: R42         LICENSE AGREEMENTS AND COMMITMENTS - MSK, CD33 and  HTML     65K 
                MabVax License Agreement (Details)                               
54: R43         LICENSE AGREEMENTS AND COMMITMENTS - Other          HTML     40K 
                agreements (Details)                                             
55: R44         LICENSE AGREEMENTS AND COMMITMENTS - Lease          HTML     60K 
                agreements (Details)                                             
56: R45         LICENSE AGREEMENTS AND COMMITMENTS - Lease costs    HTML     31K 
                (Details)                                                        
57: R46         LICENSE AGREEMENTS AND COMMITMENTS - Lease          HTML     38K 
                maturities (Details)                                             
58: R47         LICENSE AGREEMENTS AND COMMITMENTS - Lease term     HTML     26K 
                and discount rate (Details)                                      
59: R48         STOCKHOLDERS' EQUITY - Authorized, Common and       HTML     40K 
                Preferred Stock (Details)                                        
60: R49         STOCKHOLDERS' EQUITY - Stock grant agreements with  HTML     79K 
                non-employees (Details)                                          
61: R50         STOCKHOLDERS' EQUITY - Issuance of common stock     HTML     38K 
                (Details)                                                        
62: R51         SHARE-BASED COMPENSATION - 2015 Plan (Details)      HTML     31K 
63: R52         SHARE-BASED COMPENSATION - 2018 Plan (Details)      HTML     41K 
64: R53         SHARE-BASED COMPENSATION - Stock option expense     HTML     34K 
                (Details)                                                        
65: R54         SHARE-BASED COMPENSATION - Stock option activity    HTML     64K 
                (Details)                                                        
66: R55         SHARE-BASED COMPENSATION - Stock option             HTML     28K 
                unrecognized compensation (Details)                              
67: R56         SHARE-BASED COMPENSATION - Restricted Stock Unit    HTML     62K 
                Activity (Details)                                               
68: R57         Related Party Transactions (Details)                HTML     35K 
69: R58         INCOME TAXES - Expense (Details)                    HTML     35K 
70: R59         INCOME TAXES - Uncertain tax positions (Details)    HTML     23K 
71: R60         Other Benefits (Details)                            HTML     29K 
72: R61         Gain From Sale of Priority Review Voucher           HTML     34K 
                (Details)                                                        
74: XML         IDEA XML File -- Filing Summary                      XML    135K 
11: XML         XBRL Instance -- ymab-20210630x10q_htm               XML   1.59M 
73: EXCEL       IDEA Workbook of Financial Reports                  XLSX     85K 
 7: EX-101.CAL  XBRL Calculations -- ymab-20210630_cal               XML    130K 
 8: EX-101.DEF  XBRL Definitions -- ymab-20210630_def                XML    488K 
 9: EX-101.LAB  XBRL Labels -- ymab-20210630_lab                     XML   1.13M 
10: EX-101.PRE  XBRL Presentations -- ymab-20210630_pre              XML    847K 
 6: EX-101.SCH  XBRL Schema -- ymab-20210630                         XSD    162K 
75: JSON        XBRL Instance as JSON Data -- MetaLinks              325±   478K 
76: ZIP         XBRL Zipped Folder -- 0001558370-21-010959-xbrl      Zip    297K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.21.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 217 </ContextCount>
<ElementCount> 331 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 60 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 12 </UnitCount>
<MyReports>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/StatementConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/StatementConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - Consolidated Statements of Net Income/(Loss) and Comprehensive Income/(Loss) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/StatementConsolidatedStatementsOfNetIncomeLossAndComprehensiveIncomeLoss </Role>
<ShortName> Consolidated Statements of Net Income/(Loss) and Comprehensive Income/(Loss) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity </Role>
<ShortName> Consolidated Statements of Changes in Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00400 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/StatementConsolidatedStatementsOfCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 10101 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureOrganizationAndDescriptionOfBusiness </Role>
<ShortName> ORGANIZATION AND DESCRIPTION OF BUSINESS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10201 - Disclosure - BASIS OF PRESENTATION </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureBasisOfPresentation </Role>
<ShortName> BASIS OF PRESENTATION </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10401 - Disclosure - PRODUCT REVENUE </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureProductRevenue </Role>
<ShortName> PRODUCT REVENUE </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10501 - Disclosure - NET LOSS PER SHARE </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureNetLossPerShare </Role>
<ShortName> NET LOSS PER SHARE </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10601 - Disclosure - INVENTORY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureInventory </Role>
<ShortName> INVENTORY </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10701 - Disclosure - ACCRUED LIABILITIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureAccruedLiabilities </Role>
<ShortName> ACCRUED LIABILITIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10801 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitments </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10901 - Disclosure - STOCKHOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureStockholdersEquity </Role>
<ShortName> STOCKHOLDERS' EQUITY </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 11001 - Disclosure - SHARE-BASED COMPENSATION </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensation </Role>
<ShortName> SHARE-BASED COMPENSATION </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11101 - Disclosure - RELATED PARTY TRANSACTIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> RELATED PARTY TRANSACTIONS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11201 - Disclosure - INCOME TAXES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureIncomeTaxes </Role>
<ShortName> INCOME TAXES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 11301 - Disclosure - OTHER BENEFITS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureOtherBenefits </Role>
<ShortName> OTHER BENEFITS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 11401 - Disclosure - GAIN FROM SALE OF PRIORITY REVIEW VOUCHER </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureGainFromSaleOfPriorityReviewVoucher </Role>
<ShortName> GAIN FROM SALE OF PRIORITY REVIEW VOUCHER </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 20302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 30303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 30403 - Disclosure - PRODUCT REVENUE (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureProductRevenueTables </Role>
<ShortName> PRODUCT REVENUE (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureProductRevenue </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 30503 - Disclosure - NET LOSS PER SHARE (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureNetLossPerShareTables </Role>
<ShortName> NET LOSS PER SHARE (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureNetLossPerShare </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 30603 - Disclosure - INVENTORY (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureInventoryTables </Role>
<ShortName> INVENTORY (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureInventory </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 30703 - Disclosure - ACCRUED LIABILITIES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureAccruedLiabilitiesTables </Role>
<ShortName> ACCRUED LIABILITIES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureAccruedLiabilities </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 30803 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsTables </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitments </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 31003 - Disclosure - SHARE-BASED COMPENSATION (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensationTables </Role>
<ShortName> SHARE-BASED COMPENSATION (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureShareBasedCompensation </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 40201 - Disclosure - BASIS OF PRESENTATION - Accumulated deficit (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureBasisOfPresentationAccumulatedDeficitDetails </Role>
<ShortName> BASIS OF PRESENTATION - Accumulated deficit (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 40202 - Disclosure - BASIS OF PRESENTATION - Secondary public offering (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureBasisOfPresentationSecondaryPublicOfferingDetails </Role>
<ShortName> BASIS OF PRESENTATION - Secondary public offering (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 40203 - Disclosure - BASIS OF PRESENTATION - Cash and cash equivalents (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureBasisOfPresentationCashAndCashEquivalentsDetails </Role>
<ShortName> BASIS OF PRESENTATION - Cash and cash equivalents (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 40302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Credit Risk (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Credit Risk (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 40304 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurement (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFairValueMeasurementDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurement (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 40305 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition - License Revenue (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionLicenseRevenueDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition - License Revenue (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 40306 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 40401 - Disclosure - PRODUCT REVENUE - Discounts and Allowances (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureProductRevenueDiscountsAndAllowancesDetails </Role>
<ShortName> PRODUCT REVENUE - Discounts and Allowances (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 40402 - Disclosure - PRODUCT REVENUE - Concentrations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureProductRevenueConcentrationsDetails </Role>
<ShortName> PRODUCT REVENUE - Concentrations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 40501 - Disclosure - NET LOSS PER SHARE - Basic and diluted (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureNetLossPerShareBasicAndDilutedDetails </Role>
<ShortName> NET LOSS PER SHARE - Basic and diluted (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40502 - Disclosure - NET LOSS PER SHARE - Anti-dilutive securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails </Role>
<ShortName> NET LOSS PER SHARE - Anti-dilutive securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40601 - Disclosure - INVENTORY (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureInventoryDetails </Role>
<ShortName> INVENTORY (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureInventoryTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 40701 - Disclosure - ACCRUED LIABILITIES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureAccruedLiabilitiesDetails </Role>
<ShortName> ACCRUED LIABILITIES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureAccruedLiabilitiesTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 40801 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - MSK, CD33 and MabVax License Agreement (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsMskCd33AndMabvaxLicenseAgreementDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - MSK, CD33 and MabVax License Agreement (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 40802 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - Other agreements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsOtherAgreementsDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - Other agreements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 40803 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - Lease agreements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsLeaseAgreementsDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - Lease agreements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 40804 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - Lease costs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsLeaseCostsDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - Lease costs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 40805 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - Lease maturities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsLeaseMaturitiesDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - Lease maturities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 40806 - Disclosure - LICENSE AGREEMENTS AND COMMITMENTS - Lease term and discount rate (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureLicenseAgreementsAndCommitmentsLeaseTermAndDiscountRateDetails </Role>
<ShortName> LICENSE AGREEMENTS AND COMMITMENTS - Lease term and discount rate (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 40901 - Disclosure - STOCKHOLDERS' EQUITY - Authorized, Common and Preferred Stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureStockholdersEquityAuthorizedCommonAndPreferredStockDetails </Role>
<ShortName> STOCKHOLDERS' EQUITY - Authorized, Common and Preferred Stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 40902 - Disclosure - STOCKHOLDERS' EQUITY - Stock grant agreements with non-employees (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureStockholdersEquityStockGrantAgreementsWithNonEmployeesDetails </Role>
<ShortName> STOCKHOLDERS' EQUITY - Stock grant agreements with non-employees (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 40903 - Disclosure - STOCKHOLDERS' EQUITY - Issuance of common stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureStockholdersEquityIssuanceOfCommonStockDetails </Role>
<ShortName> STOCKHOLDERS' EQUITY - Issuance of common stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 41001 - Disclosure - SHARE-BASED COMPENSATION - 2015 Plan (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensation2015PlanDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - 2015 Plan (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 41002 - Disclosure - SHARE-BASED COMPENSATION - 2018 Plan (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensation2018PlanDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - 2018 Plan (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 41003 - Disclosure - SHARE-BASED COMPENSATION - Stock option expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensationStockOptionExpenseDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Stock option expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 53 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 41004 - Disclosure - SHARE-BASED COMPENSATION - Stock option activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensationStockOptionActivityDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Stock option activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 41005 - Disclosure - SHARE-BASED COMPENSATION - Stock option unrecognized compensation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensationStockOptionUnrecognizedCompensationDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Stock option unrecognized compensation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 41006 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Unit Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureShareBasedCompensationRestrictedStockUnitActivityDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Restricted Stock Unit Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 41101 - Disclosure - RELATED PARTY TRANSACTIONS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureRelatedPartyTransactionsDetails </Role>
<ShortName> RELATED PARTY TRANSACTIONS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureRelatedPartyTransactions </ParentRole>
<Position> 57 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 41201 - Disclosure - INCOME TAXES - Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureIncomeTaxesExpenseDetails </Role>
<ShortName> INCOME TAXES - Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 41202 - Disclosure - INCOME TAXES - Uncertain tax positions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureIncomeTaxesUncertainTaxPositionsDetails </Role>
<ShortName> INCOME TAXES - Uncertain tax positions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 59 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 41301 - Disclosure - OTHER BENEFITS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureOtherBenefitsDetails </Role>
<ShortName> OTHER BENEFITS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureOtherBenefits </ParentRole>
<Position> 60 </Position>
</Report>
<Report instance="ymab-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 41401 - Disclosure - GAIN FROM SALE OF PRIORITY REVIEW VOUCHER (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.ymabs.com/role/DisclosureGainFromSaleOfPriorityReviewVoucherDetails </Role>
<ShortName> GAIN FROM SALE OF PRIORITY REVIEW VOUCHER (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.ymabs.com/role/DisclosureGainFromSaleOfPriorityReviewVoucher </ParentRole>
<Position> 61 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="ymab-20210630x10q.htm"> ymab-20210630x10q.htm </File>
<File> ymab-20210630.xsd </File>
<File> ymab-20210630_cal.xml </File>
<File> ymab-20210630_def.xml </File>
<File> ymab-20210630_lab.xml </File>
<File> ymab-20210630_pre.xml </File>
<File> ymab-20210630xex31d1.htm </File>
<File> ymab-20210630xex31d2.htm </File>
<File> ymab-20210630xex32d1.htm </File>
<File> ymab-20210630xex32d2.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/country/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/21  Y-mAbs Therapeutics, Inc.         10-Q        3/31/21   76:6.3M                                   Toppan Merrill Bridge/FA
11/05/20  Y-mAbs Therapeutics, Inc.         10-Q        9/30/20   68:6.7M                                   Toppan Merrill Bridge/FA
 9/26/18  Y-mAbs Therapeutics, Inc.         8-K:5,7,9   9/25/18    4:284K                                   Toppan Merrill/FA
 8/24/18  Y-mAbs Therapeutics, Inc.         S-1                   31:12M                                    Toppan Merrill-FA
↑Top
Filing Submission 0001558370-21-010959   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 12:40:45.1am ET